Specifically, we evaluated whether the expression of tyrosine hydroxylase (TH), the rate limiting enzyme in the biosynthesis of dopamine26, could be enhanced by IN + FUS delivery of BDNF in an early-stage PD mouse model. The gene discussed is TH; the disease is Parkinson disease.